Category

CEO Spotlight

Q&A with Todd Fisher, Founder and CEO of Intraprise Health

By | CEO Spotlight

In April, HEP III made an investment in Intraprise Health (https://intraprisehealth.com/), a Certified HITRUST Assessor and award-winning eHealth technology firm. The company provides health information security products and services to assess, remediate, and monitor customers’ cyber security risk, regulatory compliance programs, organizational resilience, and third-parties’ security posture.

Todd Fisher, Founder and CEO of Intraprise Health, has spent over 25 years as a health information technology innovator, focusing most heavily on the sensitive information needs and relationship between providers, patients, and communities. He is the former CEO of MobileMD, a HEP I portfolio company that was sold to Siemens Healthcare (now Cerner) in 2011. Read More

Q&A with Randal Clark, Co-founder, CEO and President of AxiaMed

By | CEO Spotlight
Randal Clark, Co-founder, CEO and President, is the chief strategist and architect for AxiaMed. Randal has built successful payment companies, founded and oversaw a private, college-preparatory Christian school, supports orphanages in South Africa and serves on the board of Hardwired Global. He invests in ideas, charitable causes, technology, and most of all great people and corporate cultures.  Randal earned his BS in Marketing and Management from DePaul University in Chicago, Illinois. Read More

Q&A with Leah Sparks, CEO and Founder of Wildflower Health

By | CEO Spotlight

Leah Sparks has more than 15 years experience building innovative healthcare businesses in both venture-backed companies and Fortune 50 corporations. Leah founded Wildflower Health in 2012 while starting a family of her own and seeing firsthand the gaps in healthcare for consumers. Prior to starting Wildflower Health, Leah led business development for a personalized medicine startup that was acquired by Medco a few years after she joined the company. She began her career in healthcare at McKesson Corporation in corporate development, where she focused on strategy and M&A. During her tenure at McKesson, she held a variety of leadership roles including spearheading the company’s entry into the oncology market. Leah received her MBA from the University of Virginia in 2001 and holds a B.S. in Journalism from the University of Tennessee. Read More

Q&A with Clay Ritchey, CEO of Evariant

By | CEO Spotlight

Clay Ritchey is the Chief Executive Officer of Evariant. Clay has more than 20 years of experience driving growth and innovation in market leading healthcare technology organizations. As CEO, Clay is passionate about working with healthcare providers, technology partners, and his employees to transform the way that consumers, patients, and providers engage across the care continuum to build deeper relationships resulting in sustainable growth for Evariant’s customers. Read More

Q&A with Jon Hunt of Bardy Diagnostics

By | CEO Spotlight
Screen Shot 2017-03-23 at 2.56.06 PMJon Hunt is the President and CEO of Bardy Diagnostics  Prior to Bardy, Jon spent 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation in 2012). He spent the 10 years prior with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Jon began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs; he subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East, and Africa. Jon has extensive experience providing key support to cardiac electrophysiologists around the world to ensure that they, and their patients, implement new technologies safely and effectively. Read More

Steve Lefar Interview

By | CEO Spotlight

Steve Lefar is the CEO of Applied Pathways. Steve was formerly the President and CEO of Sg2, a market leader in providing analytics to providers which was acquired by MedAssets in 2015. Prior to Sg2, he was the President of MediRegs, a pioneer in SAAS applications and content for the healthcare compliance space that was acquired by WoltersKluwer. He currently is a Board Member of Enlitic and an Advisor to Evive Health. Steve also sits on the Board of the Juvenile Diabetes Foundation of Chicago, the Aptakisic-Tripp School District, and on the editorial board of the Society of Corporate Compliance and Ethics. Read More

Spotlight: Mark McAdoo, CEO, HealthQx

By | CEO Spotlight

Mark is an entrepreneur with more than 25 years of experience building ventures, commercializing healthcare solutions and driving client and partner relationships. Prior to launching HealthQx, he was the co-founder of IntelliSource Healthcare Solutions, which was sold to DST Health Solutions in 2011. Previously, he was the founder and CEO of Frontline Solutions and also served as the Director of Health Care for IBM Corporation. Mark attended Drexel University, where he currently serves on the Board of Drexel University’s LeBow School of Business. He also holds an MBA degree from Columbia Business School.  Read More

Q&A with David Michel, CEO, Catapult Health

By | CEO Spotlight

David has extensive experience in the corporate wellness arena, most notably as the co-founder, President and CEO of WinningHabits, a company that devised customized, technology-based health and wellness programs for corporations and government agencies across the country. After successfully arranging the sale of WinningHabits, he became President and CEO of InnerChange, a nationally recognized residential treatment facility operator that specializes in the care of teen girls with emotional trauma. His passion for education and personal development (as well as his passion for helping children) also inspired his co-creation of the animated television show Jay Jay the Jet Plane, which is enjoyed by children and parents across the globe.   Read More